XR11576
XR11576 (MLN576) is an orally active inhibitor of topoisomerase I and II. XR11576 shows cytotoxicity against human and murine tumor cell lines (IC50: 6-47 nM).
For research use only. We do not sell to patients.
- CAS No.: 346689-77-8
- Formula: C23H24N4O2
- Molecular Weight:388.46
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Topoisomerase Isoforms
More
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| COR-L23 | IC50 |
10.1 nM
Compound: XR-11576
|
Cytotoxicity measured using the COR-L23 parental (COR-L23/P) human non small cell lung carcinoma cell line
Cytotoxicity measured using the COR-L23 parental (COR-L23/P) human non small cell lung carcinoma cell line
|
[PMID: 11806724] |
| COR-L23 | IC50 |
12.1 nM
Compound: XR-11576
|
Cytotoxicity measured with the drug resistant human non small cell lung carcinoma cell line COR-L23 (COR-L23/R) which over expresses multidrug resistance associated with protein(MRP)
Cytotoxicity measured with the drug resistant human non small cell lung carcinoma cell line COR-L23 (COR-L23/R) which over expresses multidrug resistance associated with protein(MRP)
|
[PMID: 11806724] |
| NCI-H69 | IC50 |
1.2 nM
Compound: 11
|
Inhibitory activity against drug resistant H69/LX4 line overexpressing P-glycoprotein
Inhibitory activity against drug resistant H69/LX4 line overexpressing P-glycoprotein
|
[PMID: 11806725] |
| NCI-H69 | IC50 |
23 nM
Compound: XR-11576
|
Cytotoxicity measured using the H69 parental (H69/P) human small cell lung carcinoma cell line
Cytotoxicity measured using the H69 parental (H69/P) human small cell lung carcinoma cell line
|
[PMID: 11806724] |
| NCI-H69 | IC50 |
23 nM
Compound: 11
|
Inhibitory activity against parental human small cell lung carcinoma cell line (H69P)
Inhibitory activity against parental human small cell lung carcinoma cell line (H69P)
|
[PMID: 11806725] |
| NCI-H69 | IC50 |
29 nM
Compound: XR-11576
|
Cytotoxicity measured using the drug resistant, P-glycoprotein (Pgp) expressing human small cell lung carcinoma cell line H69/LX4
Cytotoxicity measured using the drug resistant, P-glycoprotein (Pgp) expressing human small cell lung carcinoma cell line H69/LX4
|
[PMID: 11806724] |
| P388 | IC50 |
10 nM
Compound: 11
|
Inhibitory activity against murine P388 leukemia (P388) cells.
Inhibitory activity against murine P388 leukemia (P388) cells.
|
[PMID: 11806725] |
Chemical Information
-
CAS No. 346689-77-8
-
Molecular Weight 388.46
-
Formula C23H24N4O2
-
SMILES
O=C(N[C@@H](CN(C)C)C)C1=C2C(N=C3C=CC4=C(C=CC=C4C3=N2)OC)=CC=C1
-
Synonyms
MLN576
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
[1]. Di Nicolantonio F, et al. Ex vivo characterization of XR11576 (MLN576) against ovarian cancer and other solid tumors. Anticancer Drugs. 2004 Oct;15(9):849-60. [Content Brief]
[2]. Mistry P, et al. In vitro and in vivo characterization of XR11576, a novel, orally active, dual inhibitor of topoisomerase I and II. Anticancer Drugs. 2002 Jan;13(1):15-28. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)